Flood-illuminated adaptive optics (AO) is a high-resolution retinal imaging technique that uses a flash infrared imaging light source and finely tuned deformable mirrors to continuously sample imaging waveform distortions to reduce the inherent optical aberrations of the human eye. Flood-illuminated AO has been used to study the cone mosaic in numerous retinal conditions, including acquired and inherited retinal disorders, and color deficiencies.
1–7 However, the majority of these studies assess a single imaging session for each subject and, thus, do not provide data about the intersession repeatability of cone identification via AO imaging. Intersession repeatability of cone density via flood-illuminated AO has been shown to be reliable in healthy subjects
8 and, while this provides an important reference database, it does not describe the repeatability of AO imaging for individuals with retinitis pigmentosa (RP). Qualitative patterns and findings on flood-illuminated AO imaging have been described in subjects with RP,
9 but there have not been any intersession quantitative studies to date. Recently, there have been studies investigating the repeatability of cone photoreceptor imaging via adaptive optics scanning laser ophthalmoscopes (AO-SLO) in subjects with no pathology as well as various retinal genetic diseases.
10–15 AO-SLO images are created by scanning a small point source of light in a raster fashion; when combined with a pinhole filter, this technique leads to improved axial and lateral resolution compared to flood-illuminated AO. Unfortunately, these devices remain relatively expensive compared to flood-illuminated AO cameras and require substantial infrastructure and expertise to operate. Given that repeatability studies have yet to be performed via flood-illuminated AO in subjects with RP, establishing the repeatability in this population may help to improve clinical management through more accurate prognosis, disease monitoring and assessment of future therapeutic interventions. As AO technology improves, it may provide the ability to track not only global trends in retinal degeneration, but also monitor the health of individual cones in a longitudinal manner. Therefore, the initial goal of our study was to evaluate the repeatability of flood-illuminated AO images obtained in patients with RP via intersession cone analysis. However when reviewing the data, it became apparent that the heterogeneous image quality in our study population made automated cone identification unreliable. This problem is not new with cone identification algorithms, but one that tends to be exacerbated in subjects with abnormal retinal architecture secondary to a pathologic process. Through studying repeatability in these patients, we developed two new metrics that might allow for more objective image qualification, and, thus, increased confidence in the validity of automated cone identification for a given image.